Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine, Seoul, Korea.
Gastrointest Endosc. 2017 Aug;86(2):343-348. doi: 10.1016/j.gie.2016.10.040. Epub 2016 Nov 23.
Recently, a low-volume polyethylene glycol formulation containing ascorbic acid (PEG-Asc) has proven as safe and effective as traditional 4-L PEG solutions for colonoscopy preparation. However, currently available aqueous purgative formulations are poorly tolerated. The aim of this study was to compare a split-dose 2-L PEG-Asc formulation and a 1-L PEG-Asc formulation with bisacodyl (10 mg) to determine the quality of bowel cleansing and patient tolerability.
A single-center, randomized, observer-blinded study was performed between May 2015 and September 2015. Two hundred outpatients referred for colonoscopy were prospectively enrolled and assigned to either the split-dose 2-L PEG-Asc group or the 1-L PEG-Asc with bisacodyl 10-mg group. The Boston Bowel Preparation Scale (BBPS) and Aronchick Bowel Preparation Scale (ABPS) were used to evaluate bowel cleansing. The tolerability of the regimens and satisfaction of patients was determined based on a questionnaire.
Two hundred patients received either 2-L PEG-Asc or 1-L PEG-Asc with bisacodyl. Regarding colon cleansing outcome (BBPS and ABPS), the 1-L PEG-Asc with bisacodyl group showed similar but non-inferior results compared with the 2-L PEG-Asc group on both BBPS (6.92 ± 1.63 vs 6.57 ± 1.37; P = .103) and ABPS (96% vs 95%; P = 1.000) scales. Tolerability was similar for both 1-L PEG-Asc with bisacodyl and 2-L PEG-Asc.
1-L PEG-Asc is a suitable alternative to low-volume bowel preparation for colonoscopy. Our study showed that the 1-L PEG-Asc plus bisacodyl preparation has comparable tolerability and results in adequate colon cleansing. Bowel preparation with bisacodyl and 1-L PEG-Asc is a suitable alternative to low-volume bowel preparation for colonoscopy. (Clinical trial registration number: NCT02980562.).
最近,一种含有抗坏血酸的低容量聚乙二醇配方(PEG-Asc)已被证明与传统的 4-L PEG 溶液一样安全有效,可用于结肠镜检查准备。然而,目前可用的水性泻药配方的耐受性较差。本研究旨在比较两种剂量的 2-L PEG-Asc 配方和 1-L PEG-Asc 联合 10mg 比沙可啶的配方,以确定肠道清洁质量和患者的耐受性。
这是一项于 2015 年 5 月至 2015 年 9 月在单中心进行的、随机、观察者设盲的研究。前瞻性纳入 200 名接受结肠镜检查的门诊患者,并随机分配至 2-L PEG-Asc 分剂量组或 1-L PEG-Asc 联合 10mg 比沙可啶组。采用波士顿肠道准备量表(BBPS)和 Aronchick 肠道准备量表(ABPS)评估肠道清洁度。根据问卷确定方案的耐受性和患者的满意度。
200 例患者接受了 2-L PEG-Asc 或 1-L PEG-Asc 联合 10mg 比沙可啶治疗。关于结肠清洁效果(BBPS 和 ABPS),1-L PEG-Asc 联合 10mg 比沙可啶组在 BBPS(6.92±1.63 比 6.57±1.37;P=.103)和 ABPS(96%比 95%;P=1.000)评分上与 2-L PEG-Asc 组的结果相似,但非劣效。1-L PEG-Asc 联合 10mg 比沙可啶和 2-L PEG-Asc 的耐受性相似。
1-L PEG-Asc 是结肠镜检查低容量肠道准备的合适替代方案。本研究表明,1-L PEG-Asc 联合比沙可啶的准备具有相似的耐受性,可获得充分的结肠清洁效果。1-L PEG-Asc 联合比沙可啶的肠道准备是结肠镜检查低容量肠道准备的合适替代方案。(临床试验注册号:NCT02980562.)